In the following 7 months, the patient suffered from intermittent right and left lower quadrant abdominal pain and underwent multiple radiographic studies. Pelvic sonogram was notable for a fluid collection in the posterior cul-de-sac, although the ovaries and endometrium were within normal limits. An abdominal computed tomography (CT) scan revealed a 2.5 × 4.3-cm area of inflammation at the level of the ascending colon as well as free fluid deep in the pelvis. Magnetic resonance imaging (MRI) of the pelvis confimed the CT and sonogram studies.
The patient was referred to The Johns Hopkins Hospital for additional evaluation, at which time a gadolinium-enhanced abdominal MRI revealed bowel wall thickening in a short segment of the descending colon just distal to the hepatic flexure. Her erythrocyte sedimentation rate (ESR) was 50 mm/hr (normal, 4-25 mm/hr). A subsequent colonoscopy was remarkable for patchy edema of the descending colon and aphthous ulcers in the descending colon, sigmoid colon, and rectum. A knot-like ileocecal valve lip and one anal fissure were also noted during the procedure. Histopathology revealed mild to moderate cryptitis that was most severe in the ascending and transverse colon. Esophagogastroduodenoscopy (EGD) was remarkable for gastric body and antral erythema and two aphthous ulcers in the pylorus. Histopathology of the antral biopsies was significant for moderate foveolar hyperplasia and reactive epithelial changes suggestive of chemical gastritis. The patient was diagnosed with IBD (probable Crohn's disease) and treatment was begun with 60 mg oral prednisone daily and 800 mg mesalamine three times a day.
The patient's abdominal pain clinically improved and her ESR normalized to 20 mm/hr. However, a subsequent elevation in the ESR to 43 mm/hr to led to the institution of therapy with 6-mercaptopurine (6-MP). Exacerbation of the abdominal pain resulted in additional ultrasound studies that suggested a possible inflammatory mass involving the pelvic organs. Bowel perforation with symptoms masked by steroid therapy was suspected and abdominal and pelvic CT scans revealed an 11 × 6.5 × 5-cm complex mass or fluid collection compressing the bladder and rectum (Figure 1 ). Exploratory laparotomy revealed multiple tumors from the peritoneal cavity ranging in size from 5 mm to 6 cm attached to the bladder, rectosigmoid colon, ovaries, retroperitoneum, and pericolic gutters. Histologically, the tumor nodules contained epithelioid cells arranged in a tubulopapillary formation characteristic of epithelial diffuse malignant mesothelioma ( Figure 2 ). The diagnosis of malignant mesothelioma was confirmed by immunohistochemical analysis. Of note, the cells stained positive for calretinin, a marker of cells of mesothelial origin.
The patient began treatment with six 28-day cycles of cisplatin and gemcitabine. Over the ensuing 3 months, the tumor had minimal response to this management and the medications were discontinued after three cycles secondary to severe cisplatin toxicity. The patient subsequently entered a research protocol that consisted of stripping and resection of the peritoneal mass followed by insertion of intraperitoneal cisplatin, paclitaxel, and 5-fluorodeoxyuridine (5-FU). At a 1-month follow-up an abdominal CT scan revealed no evidence of detectable tumor and no evidence of peritoneal fluid. To date, the patient remains in remission.
DISCUSSION
We have described the case of a 14-year-old female whose clinical presentation and course were suggestive of IBD but who was diagnosed, 1 year after symptom onset, with malignant peritoneal mesothelioma. The diagnosis of IBD was supported by evidence of lower quadrant abdominal pain, mural thickening of the descending colon, gross and histopathologic evidence of colitis, elevation of the ESR, and a symptomatic response to corticosteroids.
Malignant mesothelioma is an often fatal neoplasm of the simple squamous epithelium lining serous membranes. It most commonly affects the pleura, peritoneum, and pericardium and, occasionally, the tunica vaginalis and ovarian epithelium (1). It is a rare tumor, with an estimated incidence of 200-400 cases each year in the United States (2). Overall, peritoneal mesothelioma represents approximately 20% of all malignant mesothelioma cases (3) (4) (5) . Malignant peritoneal mesothelioma is especially rare in pediatric patients, as only 2-5% of cases present within the first two decades of life (6) . When it does occur in the pediatric age range, it is found more commonly in girls (7) .
Three variants of malignant mesothelioma have been noted: diffuse malignant, localized malignant, and deciduoid peritoneal (1). Of these, diffuse malignant mesothelioma accounts for the vast majority of cases and is comprised of three broad histological types: epithelial, fibrous, and mixed. Epithelial diffuse malignant mesothelioma accounts for 75% of all peritoneal mesothelioma cases, however, the fibrous and mixed types are most common in children (8, 9) .
The link between asbestos and mesothelioma, particularly of the pleural type, is an established fact. However, in adult cases, the history of asbestos exposure is less pervasive in cases of peritoneal mesothelioma (15-30%) than in pleural mesothelioma (60-70%) (10) . Nonasbestiform fibers, radiation, viruses (such as the SV40 virus), chronic inflammation, heavy metals, and genetic predisposition have also been postulated to play a role in tumor etiology in adults (8) . The association of asbestos with peritoneal mesothelioma is even less clear in the pediatric age range, as the latency period of mesothelioma is greater than 15 years in 99% of documented cases (11, 12) . In fact, asbestos, radiation, and isoniazid exposure have not been shown to have a significant association in pediatric cases, thus environmental and occupational histories have little value in providing diagnostic clues in pediatric cases (13) .
Whether in children or adults, the diagnosis of peritoneal mesothelioma is difficult and a delay in the diagnosis, or misdiagnosis, is not uncommon (5, 14, 15, 16) . Progression of symptoms can be insidious and nonspecific. Physical examination does not reveal abnormalities until the disease has advanced significantly, and standard laboratory and radiographic studies are often inconclusive (1, 17, 18) . Patients with peritoneal mesothelioma most frequently present with nonspecific abdominal pain (73%), abdominal distension (68%), and weight loss (3) (4) (5) , thus shifting the diagnosis to other possibilities such as the IBD in our patient. Ascites is present in the majority of cases, with some studies reporting a prevalence as high as 90% (2, 5, 19) .
Patients with advanced disease may show relatively normal abdominal CT scans, yet in the cases where abnormalities are detected early, the findings are often nonspecific (18) . Abnormalities described by CT and ultrasound studies include sheetlike or nodular peritoneal thickening, ascites, mesenteric involvement, and omental soft tissue masses (16, 20) . Evidence of bowel obstruction, with or without ascites, soft-tissue masses causing displacement of intrabdominal structures, and contrast studies showing diffuse extrinsic indentation of the bowel with submucosal infiltration and encapsulation are all suggestive of peritoneal mesothelioma, especially in adults with a history of asbestos exposure (5) . In retrospect, it is difficult to pinpoint the clinical findings that would have resulted in an earlier correct diagnosis in our patient. The degree of omental inflammation without grossly obvious intestinal inflammation may have been a clue. The persistence and quantity of pelvic fluid inflammation may have been another, although fluid in the pelvic cul-de-sac can be seen with IBD. We now know that the patient's initial response to steroids also helped mask the development of the malignancy.
Technological improvements in diagnostic tools may allow earlier detection of peritoneal mesothelioma such as higher-frequency transducer (7.5-MHz) ultrasound (21) . In addition, contrast-enhanced, fat-saturated MR may delineate extension of intraperitoneal tumors better than standard MR protocols, in which peritoneum is isointense with abdominal wall muscles (7) . Currently, a diagnosis of peritoneal mesothelioma requires surgical exploration, with an adequate number of biopsies taken to allow histological studies (1) . The macroscopic and histologic appearance of the tumor, together with histochemical, immunohistochemical, and at times, electron microscopic data, determines the diagnosis of mesothelioma and distinguishes it from metastatic adenocarcinoma, which is often initially suspected (1, 8) . Included in the immunohistochemical staining panel should be antibodies against calretinin, a marker of cells of mesothelial origin. Staining for calretinin has nearly 100% sensitivity and approximately 90% specificity against metastatic adenocarcinomas outside of the central nervous system (22) .
In both children and adults the prognosis is poor, with a median survival of usually less than 1 year (4-6). Treatment for mesothelioma has recently employed aggressive therapy, including stripping or resection of all peritoneal surfaces visibly involved by tumor nodules, administration of intraperitoneal chemotherapy, and second-look laparotomy. This approach has resulted in a 47% 5-year survival rate in a large group of peritoneal surface malignancy patients (2) .
A very high index of suspicion is required to include the diagnosis of malignant peritoneal mesothelioma in pediatric cases with abdominal pain, however, significant omental inflammation and peritoneal fluid should be kept in mind as potential clues for this diagnosis. Given the improvements in therapies in recent years, the significance of earlier diagnosis may have an even greater impact on patient prognosis.
